Quantcast

Latest Heart Protection Study Stories

2013-02-27 11:02:12

The largest randomized study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side-effects when it is combined with statin treatment. Results from the HPS2-THRIVE study (Heart Protection Study 2 — Treatment of HDL to Reduce the Incidence of Vascular Events), including the reasons patients stopped the study treatment, are published online today (Wednesday) in the European Heart Journal. Niacin...

Merck Says Stop Prescribing Tredaptive
2013-01-12 08:05:31

redOrbit Staff & Wire Reports — Your Universe Online New Jersey-based pharmaceutical company Merck is telling doctors to stop prescribing the cholesterol drug Tredaptive following a study that casts doubt on the medication´s efficacy and safety. Tredaptive, which has not yet been approved in the US, is currently sold in more than three dozen countries worldwide, according to the Associated Press. In addition to putting a halt to prescriptions, Merck is also advising...

2012-03-27 05:16:48

(Ivanhoe Newswire)-- Many women use vitamin E for their skin, but theories have circulated that taking vitamin E could also impact a women's heart. A recent study investigated the effectiveness of vitamin E in the prevention of heart failure. With the study consisting of nearly 40,000 women aged 45 or older and in good health. Researchers studied these women for about 10 years to determine if taking the supplement increased heart failure risk. Although 220 heart failure cases were...

2011-09-12 23:28:56

Among patients who have had an ischemic stroke, use of cholesterol-lowering statin medications is not associated with subsequent intracerebral hemorrhage (bleeding in the brain), according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals. According to background information in the article, after stroke or transient ischemic attack, patients are at increased risk for recurrent events. Results from the Stroke Prevention by Aggressive Lowering of...

2011-06-08 14:32:00

Increased risk of muscle injury cited SILVER SPRING, Md., June 8, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy, particularly during the first 12 months of use. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) The agency is recommending...

2011-05-19 06:53:48

(Ivanhoe Newswire) -- Regardless of the beneficial effects of both aspirin and simvastatin in treating heart disease, neither drug appears to offer any benefit to individuals suffering from pulmonary artery hypertension (PAH), a condition that accounts for over 1,000 new cases annually. Pulmonary arterial hypertension is a progressive disorder characterized by abnormally high blood pressure (hypertension) in the pulmonary artery, the blood vessel that carries blood from the heart to the...

2011-01-10 15:36:28

A computer decision model suggests that for patients with a history of bleeding within the brain, the risk of recurrence associated with statin treatment may outweigh the benefit of the drug in preventing cardiovascular disease, according to a report posted online today that will appear in the May print issue of Archives of Neurology, one of the JAMA/Archives journals. The benefits of statins for reducing the risk of heart disease and stroke are well established, but more widespread use of...

2010-11-10 12:43:34

Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia. Statins are a class of drugs commonly used in the United States to lower cholesterol and reduce the risk of cardiovascular disease. While study results to date have shown that short-term use of statins has...

2010-03-19 10:00:00

Highest approved dose of cholesterol-lowering medication could cause harm to muscles SILVER SPRING, Md., March 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for increased risk of muscle injury from the cholesterol-lowering medication Zocor (simvastatin) 80 mg. Although muscle injury (called myopathy) is a known side effect with all statins, today's warning highlights the greater risk of developing...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related